Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela L Beatty

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|May 9, 2013
Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomasPamela L Beatty, Olivera J Finn
Current Opinion in Immunology|January 23, 2016
Cancer immunopreventionOlivera J Finn, Pamela L Beatty
Cancer Research|June 30, 2011
Tumor immunology: basic and clinical advancesPamela L Beatty, Sandra Cascio, Eric Lutz
Molecular Carcinogenesis|April 26, 2020
Myeloid derived suppressor cells in cancer, premalignancy and inflammation: A roadmap to cancer immunopreventionUmayal Sivagnanalingam, Pamela L Beatty, Olivera J Finn
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancerPamela L Beatty, Scott E Plevy, Antonia R Sepulveda, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancerPamela L Beatty, Sowmya Narayanan, Jean Gariépy, et al.
Frontiers in Immunology|July 6, 2019
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in CancerPeiwen Ma, Pamela L Beatty, John McKolanis, et al.
Immunologic Research|July 1, 2011
Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomasOlivera J Finn, Kira R Gantt, Andrew J Lepisto, et al.
Cancer Immunology Research|April 30, 2014
Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillanceUzoma K Iheagwara, Pamela L Beatty, Phu T Van, et al.
Pancreas|January 20, 2010
Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitisDeepak K Kadayakkara, Pamela L Beatty, Michael S Turner, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|May 9, 2013
Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomasPamela L Beatty, Olivera J Finn
Current Opinion in Immunology|January 23, 2016
Cancer immunopreventionOlivera J Finn, Pamela L Beatty
Cancer Research|June 30, 2011
Tumor immunology: basic and clinical advancesPamela L Beatty, Sandra Cascio, Eric Lutz
Molecular Carcinogenesis|April 26, 2020
Myeloid derived suppressor cells in cancer, premalignancy and inflammation: A roadmap to cancer immunopreventionUmayal Sivagnanalingam, Pamela L Beatty, Olivera J Finn
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancerPamela L Beatty, Scott E Plevy, Antonia R Sepulveda, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 25, 2010
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancerPamela L Beatty, Sowmya Narayanan, Jean Gariépy, et al.
Frontiers in Immunology|July 6, 2019
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in CancerPeiwen Ma, Pamela L Beatty, John McKolanis, et al.
Immunologic Research|July 1, 2011
Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomasOlivera J Finn, Kira R Gantt, Andrew J Lepisto, et al.
Cancer Immunology Research|April 30, 2014
Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillanceUzoma K Iheagwara, Pamela L Beatty, Phu T Van, et al.
Pancreas|January 20, 2010
Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitisDeepak K Kadayakkara, Pamela L Beatty, Michael S Turner, et al.
Pageof 2